OPICAPONE EFFECT ON SLEEP DISORDERS IN FLUCTUATING PARKINSON'S DISEASE PATIENTS: FINDINGS FROM THE OASIS TRIAL

被引:0
|
作者
Ferreira, J. J. [1 ,2 ]
Gago, M. F. [3 ]
Costa, R. [4 ]
Fonseca, M. M. F. [4 ]
Almeida, J. [4 ]
Rocha, J-F [4 ]
Holenz, J. [4 ]
Trenkwalder, C. [5 ]
机构
[1] CNS Campus Neurol, Torres Vedras, Portugal
[2] Univ Lisbon, IMM Inst Med Mol Joao Lobo Antunes, Fac Med, Lisbon, Portugal
[3] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Braga, Portugal
[4] BIAL Portela & Ca SA, Coronado, Portugal
[5] Paracelsus Elena Klin, Kassel, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
O_24
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Effect of zonisamide on sleep and rapid eye movement sleep behavioral disorders in patients with Parkinson's disease: A randomized control trial
    Kataoka, Hiroshi
    Isogawa, Masahiro
    Nanaura, Hitoki
    Kurakami, Hiroyuki
    Hasebe, Miyoko
    Kinugawa, Kaoru
    Kiriyama, Takao
    Izumi, Tesseki
    Kasahara, Masato
    Sugie, Kazuma
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 11
  • [22] Opicapone in clinical practice in Parkinson's disease German patients with motor fluctuations: Findings from the OPTIPARK study
    Reichmann, Heinz
    Lees, Andrew
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 270 - 270
  • [23] Opicapone in clinical practice in Parkinson's disease UK patients with motor fluctuations: Findings from the OPTIPARK study
    Lees, Andrew
    Reichmann, Heinz
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 269 - 270
  • [24] Addition of Opicapone to Safinamide in Parkinson's Disease patients
    Russo, M.
    Carrarini, C.
    Dono, F.
    Di Pietro, M.
    Rispoli, M.
    Ferri, L.
    Onofrj, M.
    MOVEMENT DISORDERS, 2019, 34 : S80 - S80
  • [25] Hepatic safety of opicapone in Parkinson's disease patients
    Lopes, N.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Santos, A.
    Oliveira, C.
    Costa, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S101 - S101
  • [26] Opicapone in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study
    Lees, A.
    Reichmann, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S219 - S219
  • [27] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C. W.
    Kieburtz, K. D.
    Liang, G. S.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    MOVEMENT DISORDERS, 2019, 34 : S7 - S7
  • [28] Opicapone in Parkinson's German Patients with Motor Fluctuations: findings from the OPTIPARK Study
    Reichmann, H.
    Lees, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 354 - 355
  • [29] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C.
    Kieburtz, K.
    Liang, G.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    MOVEMENT DISORDERS, 2019, 34 : S62 - S62
  • [30] Sleep disturbances in patients with Parkinson's disease: Polysomnographic findings
    Cheon, S.
    Lee, M. S.
    Yang, C. K.
    Park, M. J.
    Kim, J. W.
    MOVEMENT DISORDERS, 2006, 21 : S491 - S491